Compare ACXP & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACXP | PMAX |
|---|---|---|
| Founded | 2017 | 2019 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 4.5M |
| IPO Year | 2021 | 2024 |
| Metric | ACXP | PMAX |
|---|---|---|
| Price | $3.22 | $3.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $143.67 | N/A |
| AVG Volume (30 Days) | 51.4K | ★ 1.6M |
| Earning Date | 11-12-2025 | 09-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $4,799,100.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.17 | $1.56 |
| 52 Week High | $25.00 | $25.44 |
| Indicator | ACXP | PMAX |
|---|---|---|
| Relative Strength Index (RSI) | 32.54 | 74.38 |
| Support Level | $3.17 | $1.56 |
| Resistance Level | $3.50 | $3.04 |
| Average True Range (ATR) | 0.35 | 0.29 |
| MACD | -0.06 | 0.16 |
| Stochastic Oscillator | 2.62 | 97.77 |
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.